The team investigated an IgE antibody called MOv18, exploring its ability to activate immune cells from patients at Guy’s and St Thomas’ NHS Foundation Trust with ovarian cancer and its influence on ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, according to a study published in Advanced Science. Inside cells, DNA mixes ...

A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancers origins within the body as well as insights into new treatment strategies for Ovarian cancer.

New research has revealed how a novel IgE antibody (MOv18) therapy reactivates the immune cells of ovarian cancer patients, enabling them to fight the disease more effectively. Conducted by ...

but also the cancer stem cells, one can eradicate the CSCs that would repopulate the tumor," Herzog said. The 81 patients with platinum-resistant ovarian cancer (cancer recurrence within six ...